Literature DB >> 9725364

Results of operation in Mycobacterium avium-intracellulare lung disease.

K G Nelson1, D E Griffith, B A Brown, R J Wallace.   

Abstract

BACKGROUND: Although operation remains part of the management of Mycobacterium avium-intracellulare lung disease, few series have assessed operation in the era of better therapeutic drugs (especially clarithromycin).
METHODS: From January 1, 1989, through June 30, 1997, 28 patients with M avirum-intracellulare lung disease underwent pulmonary resection. All were receiving multidrug therapy (17 of 28 were receiving clarithromycin) before and after operation. Eight patients underwent pneumonectomy (6 right, 2 left); 20 patients underwent partial resections including 18 with upper lobe lobectomies (14 right, 4 left). The most common indications for operation were medical treatment failure (15) and as part of initial therapy (9).
RESULTS: Mean postoperative follow-up was 39 months. Complications occurred in 9 of 28 patients (32%), and included persistent air leak requiring surgical correction (5), early postoperative death (2), and late bronchopleural fistulae (1 patient). Twenty-three of 26 patients were known to be acid fast bacilli culture negative within 1 month of operation. Only 1 of 26 patients who survived 2 years is known to have had a relapse.
CONCLUSIONS: Operation continues to play an important role in treatment of M avium-intracellulare lung disease. More than 90% of patients become culture negative and remain so when they continue to receive drugs. Although morbidity is relatively high, it is manageable and the 12-month mortality in the current series was low (7%).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725364     DOI: 10.1016/s0003-4975(98)00401-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 2.  Risk-benefit assessment of therapies for Mycobacterium avium complex infections.

Authors:  D E Griffith
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

3.  Acute empyema with intractable pneumothorax associated with ruptured lung abscess caused by Mycobacterium avium.

Authors:  Katsuyuki Asai; Norikazu Urabe
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-06-15

4.  Treatment of Non-Tuberculous Mycobacterial Lung Disease.

Authors:  Julie V Philley; Mary Ann DeGroote; Jennifer R Honda; Michael M Chan; Shannon Kasperbauer; Nicholas D Walter; Edward D Chan
Journal:  Curr Treat Options Infect Dis       Date:  2016-10-11

Review 5.  Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.

Authors:  Janice M Leung; Kenneth N Olivier
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

6.  Management of pulmonary nontuberculous mycobacterial disease.

Authors:  Kathleen L Horan; Shawn J Skerrett
Journal:  F1000 Med Rep       Date:  2009-12-15

7.  HRCT in detection of pulmonary infections from nontuberculous mycobacteria: personal experience.

Authors:  I Ferrara; S Cappabianca; L Brunese; T Valente; E Muto; R Muto; A Rotondo
Journal:  Radiol Med       Date:  2009-03-11       Impact factor: 3.469

Review 8.  Surgical treatment of nontuberculous mycobacterial lung disease.

Authors:  Yuji Shiraishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-04-17

9.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

10.  The outcomes of anatomical lung resection for nontuberculous mycobacterial lung disease.

Authors:  Tadashi Sakane; Katsunari Matsuoka; Sakiko Kumata; Risa Watanabe; Tetsu Yamada; Takahisa Matsuoka; Shinjiro Nagai; Mitsuhiro Ueda; Yoshihiro Miyamoto
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.